17 March 2010
ECO Animal Health establishes a joint venture for the distribution of animal
health products in North America.
ECO Animal Health Ltd and Pharmgate LLC of Ramsey, New Jersey are pleased to
announce the formation of Pharmgate Animal Health LLC. This jointly-owned
company will distribute its owners' veterinary products in the North American
livestock and poultry markets.
The new company will benefit from the extensive manufacturing and product
development experience of its owners to bring to market their ranges of
extensively used medicated feed additives and innovative new therapeutic
compounds for livestock and poultry. Its low-cost structure will optimize the
supply chain for a range of the most broadly utilized drugs and will be backed
by a specialist sales and technical team.
Marc Loomes, chief executive of ECO Animal Health Group plc (AIM: EAH), the
parent of ECO Animal Health Ltd, said, "This is an important step in the global
commercialisation of Aivlosin®, our novel antibiotic for the treatment of
enteric and respiratory disease in swine and poultry. Pre-approval studies in
the US market have shown similar performance of Aivlosin® to that seen in
markets where the product is already being successfully sold, including Europe,
Central and Latin America, China, Japan, South East Asia and Africa. After
evaluating many options we have selected Pharmgate as our partner in North
America. Pharmgate shares ECO's marketing philosophy and pursuit of lean and
agile field operations."
Colin Gray, general manager of Pharmgate, part of Jinhe Biotechnology Ltd of
China, commented, "We are excited to take this important step in the forward
integration of Pharmgate into the North American market. Our FDA-approved
manufacturing facilities in China meet the highest international quality, safety
and environmental standards and are well-known to the industry. We look forward
to satisfying our customers' requirements for a streamlined, no-nonsense source
of key animal health products."
Contacts:
ECO Animal Health Group plc Marc Loomes +44 (0) 20 8447 8899
Spiro Financial Anthony Spiro +44 (0) 20 8336 6196
Cenkos Securities plc Stephen Keys +44 (0) 20 7397 8926
-----------------------------------------------------
About ECO Animal Health Ltd
ECO Animal Health based in London U.K. is a leader in the development,
registration and marketing of pharmaceutical products for global animal health
markets. Its products for these growth markets promote well-being in animals and
include the novel macrolide antibiotic, Aivlosin®, as well as a range of generic
therapeutic products.
About Pharmgate LLC
Pharmgate LLC is the wholly-owned US subsidiary of Jinhe Biotechnology Co.,
Ltd., P. R. China, the world leader in the production of chlortetracycline
feed grade, chlortetracycline hydrochloride, salinomycin and other animal health
compounds. The company has marketing or supply approvals for these products in
most major markets throughout the world.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.